3.11MMarket Cap0.00P/E (TTM)
3.800High3.710Low7.79KVolume3.800Open3.630Pre Close29.17KTurnover1.07%Turnover RatioLossP/E (Static)837.31KShares8.92052wk High-0.43P/B2.71MFloat Cap2.23052wk Low--Dividend TTM729.47KShs Float6199.990Historical High--Div YieldTTM2.48%Amplitude2.230Historical Low3.744Avg Price1Lot Size
Scinai Immunotherapeutics Stock Forum
9 MINUTES AGO, 6:31 AM EDT
VIA PR NEWSWIRE
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biotechnology company known for its focus on developing inflammation and immunology (I&I) biological products, has announced successful in-vivo preclinical study results. The results pertain to its innovative anti IL-17A/F VHH antibody fragment, known as 'NanoAb', which fun...
No comment yet